The great escape: Pseudomonas breaks out of the lung

Angelica Zhang1, Stephanie M Rangel1, Alan R Hauser2

  • 1Department of Microbiology/Immunology, Northwestern University, Feinberg School of Medicine, Chicago Illinois, USA.

Insights

Pseudomonas aeruginosa infections cause hospital-acquired pneumonia. Its ExoS toxin disrupts lung cells, breaching the pulmonary-vascular barrier and spreading bacteria to the bloodstream.

Area of Science:

  • Microbiology and Immunology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Pseudomonas aeruginosa is a Gram-negative bacterium frequently causing hospital-acquired infections.
  • Antibiotic resistance in P. aeruginosa necessitates understanding its virulence mechanisms.
  • The type III secretion system (T3SS) is a key virulence factor, delivering effector proteins like ExoS into host cells.

Purpose of the Study:

  • To investigate the role of ExoS, a T3SS effector protein, in P. aeruginosa-induced pneumonia.
  • To elucidate the mechanisms by which ExoS contributes to lung injury and bacterial dissemination.
  • To explore novel in vivo techniques for studying ExoS function.

Main Methods:

  • Utilized a mouse model of P. aeruginosa pneumonia.
  • Assessed the impact of ExoS ADP-ribosyltransferase (ADPRT) activity on host cells.
  • Employed advanced techniques to visualize and analyze ExoS function in vivo.

Main Results:

  • ExoS ADPRT activity induced the formation of 'fields of cell injection' (FOCI) in lung tissue.
  • FOCI comprised ExoS-injected type I pneumocytes, exhibiting compromised integrity.
  • ExoS-mediated damage led to pulmonary-vascular barrier disruption and bacterial dissemination to the bloodstream.

Conclusions:

  • ExoS is a critical virulence factor in P. aeruginosa pneumonia, directly impacting lung cell function.
  • The disruption of the pulmonary-vascular barrier by ExoS facilitates systemic bacterial spread.
  • Novel in vivo methodologies provide valuable insights into T3SS effector protein function during infection.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
13
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K